Sector Gamma AS’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62,000
Closed -$8.23M 38
2022
Q1
$8.23M Buy
+62,000
New +$7.44M 1.79% 20
2018
Q4
Sell
-91,453
Closed -$7.24M 34
2018
Q3
$7.24M Sell
91,453
-308,841
-77% -$23.4M 1.13% 22
2018
Q2
$28.1M Sell
400,294
-2,724
-0.7% -$196K 4.67% 7
2018
Q1
$28.2M Sell
403,018
-45,368
-10% -$3.14M 5.08% 6
2017
Q4
$31.1M Buy
448,386
+78,050
+21% +$5.26M 5.23% 6
2017
Q3
$25.1M Buy
+370,336
New +$23.4M 3.82% 12

Other funds holding AZN

Sector Gamma AS's AZN Position: Q2 2022 in Review

Sector Gamma AS sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 62,000 shares — an estimated $8.23M sold.

Sector Gamma AS first reported a position in AZN in Q3 2017 and held it in 6 quarters. The position peaked at $31.1M in Q4 2017. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Sector Gamma AS reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
  • Sector Gamma AS sold 62,000 AstraZeneca shares in Q2 2022, an estimated $8.23M.
  • Sector Gamma AS first reported a position in AstraZeneca in Q3 2017 and held it in 6 quarters.
  • Sector Gamma AS's AstraZeneca position peaked at $31.1M in Q4 2017.
  • 1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Sector Gamma AS's 13F filing for Q2 2022, filed 5 Aug 2022.